Flagship @ JPM 2024

The event will feature Frances Arnold, Nobel Laureate, Generate Biomedicines board member, and Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry at the California Institute of Technology; Sue Desmond-Hellmann, former CEO of the Bill and Melinda Gates Foundation; Cynthia Patton, General Counsel and Secretary of Tessera; and Flagship Pioneering Senior Partner Justine Levin-Allerhand.

At a time when companies increasingly recognize that diversity drives resilience, innovation, and success, our featured speakers will reflect on their own experiences and discuss where they see opportunities for impact through board engagement.

Flagship CEO & Founder Noubar Afeyan shares his outlook for 2024 in a discussion with Endpoints News' Executive Editor Drew Armstrong.

Watch the CEO Chat with Michelle Werner, CEO of Alltrna here. 

Watch the Company Chat with Jake Rubens, President of Quotient Therapeutics, here. 

Watch the CEO Chat with Lovisa Afzelius, Co-founder and CEO of Apriori Bio, here. 

Watch the CEO Chat with Margo Georgiadis, Co-founder and CEO of Montai, here. 

Watch the CEO Chat with Steve Hahn, CEO of Harbinger Health here.

Watch the CEO Chat with Mahesh Karande, President and CEO of Omega, here. 

Watch the CEO Chat with Foghorn CEO Adrian Gottshallk here. 

Advances in genetics, machine learning, and human biology are deepening our ability to find associations between patients’ biology and disease pathways, opening up entirely new frontiers for therapeutic intervention. Redefining patient populations based on shared biology offers the opportunity to dramatically scale the creation of new medicines and places the treatment of rare and ultra-rare diseases within reach. At the same time, using the power of genetics to drive small molecule drug discovery has, for the first time, created new ways to treat common diseases with a level of precision that, for the last two decades, has been reserved for rare diseases. Join Christopher Austin, CEO of Vesalius Therapeutics and CEO-Partner, Flagship Pioneering, Jason Park, CEO of Empress Therapeutics and Operating Partner, Flagship Pioneering, and Michelle Werner, CEO of Alltrna and CEO-Partner, Flagship Pioneering will join Robert Plenge, Executive Vice President, Chief Research Officer, Head of Research, Bristol Myers Squibb to discuss the opportunities for bioplatforms to dramatically scale the creation of new medicines and put the treatment of rare and ultra-rare diseases within reach while also finding novel ways to treat common diseases with a level of precision that, for the last two decades, has been reserved for rare diseases.

Women trailblazers are transforming business and together, building the next generation of leaders through mentorship and sharing of hard-earned wisdoms gleaned from years of career experiences. Drawing inspiration from the book, “Women Mean Business,” which launched earlier this year, join us for an intimate gathering of women leaders in tech and biotech as we bring this important conversation into the biopharma realm.

Hear extraordinary women leaders Margo Georgiadis, Co-Founder & CEO of Montai and Flagship Pioneering CEO-Partner; Cindy Kent, former Chief Operating Officer of Everly Health;  Edie Fraser, Chair of the Women Business Collaborative; and Audrey Greenberg, Co-Founder & CBO of the Center for Breakthrough Medicines, in conversation with Christine Heenan, Flagship Pioneering Chief Communications Officer & Executive Partner, discussing the most valuable insights that have advanced their careers, the behaviors that sparked innovation and drive, and the dynamics of leadership today that will influence the women leaders of tomorrow.

Charlotte Allerton, Head of Discovery and Early Development at Pfizer joins Paul Biondi, Flagship Executive Partner and President of Pioneering Medicines, for a discussion about pioneering partnerships that leverage capabilities from across the biopharma industry to develop potentially transformational therapeutics, including the strategic alliance between Pfizer and Flagship Pioneering.

Watch the CEO Chat with Chris Austin, CEO of Vesalius Therapeutics, here.

Watch the CEO Chat with Jason Park, CEO of Empress Therapeutics, here. 

Watch CEO Chat with Eric Shaff, CEO of Seres Therapeutics, here. 

Watch the CEO Chat with Jason Gardner, CEO of Ampersand Biomedicines here. 

Watch the CEO Chat with Lovisa Afzelius, Co-founder and CEO of Metaphore Biotechnologies here. 

Fabrice Chouraqui, CEO of Cellarity, and Uli Stilz, Head of Novo Nordisk’s Bio Innovation Hub, join Paul Biondi, Flagship Executive Partner and President of Pioneering Medicines, for a discussion about the recently announced research collaboration between the three companies to unlock a new therapy for Metabolic Steatohepatitis (MASH), for which there are no currently approved treatments.

Join Professor Tan Sze Wee, Assistant Chief Executive, A*STAR’s Biomedical Research Council, and Professor Lucy Chappell, CEO of the UK National Institute for Health Research, in conversation with Flagship Chair of Asia Pacific and Strategic Advisor, Flagship Pioneering, André Andonian, for a discussion about how connecting life sciences ecosystems around the globe can unlock opportunities for innovation and value creation by building on our complementary strengths.

With the explosion of different modalities and the incredible speed and potential of the AI/ML revolution, partnerships between platform companies and larger pharma are more critical than ever to accelerate drug development. John Lepore, CEO of ProFound Therapeutics and CEO-Partner, Flagship Pioneering, Mike Nally, CEO of Generate:Biomedicines and CEO-Partner, Flagship Pioneering, and Luciano Rossetti, Chief Medical Officer, Flagship Pioneering and Head of Research & Development, Pioneering Medicines will join Amanda Kay, Chief Business Development Officer and Senior Partner, Flagship Pioneering to discuss the opportunity that Flagship’s innovative bioplatforms offer in terms of novel partnerships with pharma to bring about new therapeutics.

Flagship Pioneering Founder and CEO Noubar Afeyan sits down with Marc Casper, CEO of Thermo Fisher Scientific, for a conversation on macroeconomic trends, global market dynamics, and the future of enabling technologies in powering biotech and creating novel therapies.

Read more on the recently announced partnership between Thermo Fisher and Flagship to develop and commercially scale multiproduct platforms on an accelerated basis.

Mahesh Karande, President & CEO of Omega Therapeutics, and Uli Stilz, Head of Novo Nordisk’s Bio Innovation Hub, join Luciano Rossetti, Chief Medical Officer, Flagship Pioneering and Head of Research & Development, Pioneering Medicines, for a discussion about the recently announced research collaboration between the three companies to develop a novel therapeutic for obesity management.

Last year was a landmark year in the history of technology with the explosive rise of generative AI. While the application of AI and machine learning in the life sciences is not new, the emergence of increasingly powerful generative AI models has unlocked new drivers of R&D innovation and economic productivity gains in our industry.

Join Anthony Costa, Global Lead, Life Sciences Alliances, NVIDIA; Margo Georgiadis, Co-Founder and CEO of Montai Health and CEO-Partner, Flagship Pioneering; and Kathleen Sullivan, Senior Director, Microsoft Health Futures, for a conversation moderated by Marcello Damiani, Senior Partner, Flagship Pioneering, reflecting on the learnings these leaders have gleaned one year into the generative AI era and the implications on the future of capital investment, talent, and value creation in the life sciences.